thiophenes has been researched along with Dermatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, H; Kim, M; Rho, S | 1 |
| Chen, M; da Silva, AA; do Carmo, JM; Hall, JE; Ostrowski, M; Rajagopalan, S; Ryan, MJ; Xiang, L; Ying, Z | 1 |
| SAITO, T; SUGAI, T | 1 |
3 other study(ies) available for thiophenes and Dermatitis
| Article | Year |
|---|---|
Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Dermatitis; Drug Combinations; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Preservatives, Pharmaceutical; Risk Factors; Sulfonamides; Thiophenes; Timolol; Young Adult | 2021 |
Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle.
Topics: Animals; Blood Pressure; Cell Line; Crosses, Genetic; Dermatitis; Humans; I-kappa B Kinase; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myosin Light Chains; Myosin-Light-Chain Kinase; Myosins; Peptide Fragments; Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Thiophenes; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2013 |
[TREATMENT OF SEVERAL SKIN DISEASES WITH REDUCDYN].
Topics: Adolescent; Biomedical Research; Child; Cysteine; Dermatitis; Drug Therapy; Eczema; Fructose; Humans; Pruritus; Psoriasis; Thiophenes | 1964 |